Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies (Q42914870)
Jump to navigation
Jump to search
scientific article published on 6 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies |
scientific article published on 6 September 2010 |
Statements
1 reference
Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies (English)
1 reference
1 reference
Sheelagh Frame
1 reference
Christophe Le Tourneau
1 reference
Valérie Laurence
1 reference
Catherine Delbaldo
1 reference
Karina Vera
1 reference
Veronique Girre
1 reference
Judy Chiao
1 reference
Sian Armour
1 reference
Simon R Green
1 reference
Athos Gianella-Borradori
1 reference
Veronique Diéras
1 reference
Eric Raymond
1 reference
6 September 2010
1 reference
1 reference
Identifiers
1 reference